Form 4: Kamada Ltd. Director Benjamin Dekel Adjusts Stock Options

Kamada Ltd. director Benjamin Dekel reported adjustments to his stock options on April 7, 2026, reflecting a dividend distribution and vesting schedules.

Summary

• Benjamin Dekel, a Director at Kamada Ltd. (KMDA), filed a Form 4 detailing changes in his beneficial ownership of stock options.
• The transactions occurred on April 7, 2026, and involve adjustments to the exercise prices of several employee stock options.
• These adjustments are a result of a cash dividend distribution declared by the company's board of directors on March 11, 2026, and are in accordance with the Company's 2011 Share Award Plan.
• The exercise prices were convenience conversions from NIS to USD based on the exchange rate of April 6, 2026.
• Dekel holds a total of 32,000 shares underlying these options, with various vesting dates ranging from September 7, 2024, to September 7, 2027.
• The options are held by a trustee under the Company's 2011 Share Award Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine adjustments to stock options due to a dividend distribution rather than significant new financial performance or strategic shifts.

Positives

• Director Benjamin Dekel's stock options have been adjusted to reflect a dividend distribution, which is a positive sign of shareholder returns.
• The adjustments are made in accordance with the company's established share award plan, indicating adherence to corporate governance policies.
• The options have staggered vesting schedules, suggesting a long-term commitment from the director.

Negatives

• The filing does not indicate any new acquisitions or disposals of securities, only adjustments to existing options.
• The specific impact of the dividend distribution on the overall value of the options is not detailed in this filing.

Risks

• The exercise prices of the options are subject to currency exchange rate fluctuations, as indicated by the convenience conversion from NIS to USD.
• The value of the options is tied to the future performance of Kamada Ltd.'s stock.

Future Outlook

The filing primarily concerns historical transactions and adjustments to existing stock options, and does not contain specific forward-looking financial guidance.

Management Comments

• The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026.
• There are no other changes to the terms and conditions of the option award.

Industry Context

StockSavvy.ai notes that adjustments to executive stock options due to dividend distributions are common within the biotechnology and pharmaceutical sectors, reflecting a mechanism to maintain the intended value of equity compensation following significant corporate actions.

Corporate Governance

Stakeholder Impact

• Shareholders: The dividend distribution directly benefits shareholders, and the option adjustments ensure that executive compensation remains aligned with the company's value.
• Employees: The adjustment to options under the Share Award Plan reinforces the incentive structure for key personnel.
• Management: The reporting person, Benjamin Dekel, has had his stock options adjusted, reflecting a standard corporate practice.

Next Steps

• The options will continue to vest according to their scheduled dates.
• The options will expire on March 7, 2030.

Key Dates

Keywords

Kamada Ltd., KMDA, Form 4, Stock Options, Beneficial Ownership, Director, Benjamin Dekel, SEC Filing, Share Award Plan, Dividend Distribution